Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)
Clinical trial NCT02132754 · COMPLETED
Trial details
- NCT number
- NCT02132754
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-27
- Primary completion
- 2019-07-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.